Murchinson Ltd. Spero Therapeutics, Inc. Transaction History

Murchinson Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.35 - $1.79 $15,133 - $20,065	11,210 Added 1.3%	873,910 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$1.2 - $1.63 $120,000 - $163,000	100,000 Added 13.11%	862,700 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$1.42 - $1.95 $60,947 - $83,695	-42,921 Reduced 5.33%	762,700 $1.11 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $2.0 $57,943 - $85,842	42,921 Added 5.63%	805,621 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $518,636 - $1.68 Million	762,700 New	762,700 $1.53 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

Stay updated on Murchinson Ltd. with notifications on news.